Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper
Oliver Pfaar, P. Démoly, Roy Gerth van Wijk, et al.
Allergy (2014) Vol. 69, Iss. 7, pp. 854-867
Closed Access | Times Cited: 388

Showing 1-25 of 388 citing articles:

International consensus on allergy immunotherapy
Marek Jutel, Ioana Agache, С. Бонини, et al.
Journal of Allergy and Clinical Immunology (2015) Vol. 136, Iss. 3, pp. 556-568
Open Access | Times Cited: 508
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Sarah K. Wise, Sandra Y. Lin, Elina Toskala, et al.
International Forum of Allergy & Rhinology (2018) Vol. 8, Iss. 2, pp. 108-352
Open Access | Times Cited: 439
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
Ignacio J. Ansotegui, Giovanni Melioli, Giorgio Walter Canonica, et al.
World Allergy Organization Journal (2020) Vol. 13, Iss. 2, pp. 100080-100080
Open Access | Times Cited: 396
Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care
Ludger Klimek, Karl‐Christian Bergmann, Tilo Biedermann, et al.
Allergo Journal International (2017) Vol. 26, Iss. 1, pp. 16-24
Open Access | Times Cited: 385
Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Claus Bachert, Albrecht Bufe, et al.
Allergo Journal International (2014) Vol. 23, Iss. 8, pp. 282-319
Open Access | Times Cited: 336
Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper
Mohamed H. Shamji, Jasper H. Kappen, Mübeccel Akdiş, et al.
Allergy (2017) Vol. 72, Iss. 8, pp. 1156-1173
Open Access | Times Cited: 326
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta‐analysis
Sangeeta Dhami, Ulugbek Nurmatov, Stefania Arasi, et al.
Allergy (2017) Vol. 72, Iss. 11, pp. 1597-1631
Open Access | Times Cited: 309
Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis
Lei Cheng, Jianjun Chen, Qing‐Ling Fu, et al.
Allergy Asthma and Immunology Research (2018) Vol. 10, Iss. 4, pp. 300-300
Open Access | Times Cited: 279
Allergen Immunotherapy in Children User’s Guide
Montserrat Álvaro‐Lozano, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. S25, pp. 1-101
Open Access | Times Cited: 265
EAACI Position paper on the standardization of nasal allergen challenges
Josep M. Augé, Julia Vent, Ioana Agache, et al.
Allergy (2018) Vol. 73, Iss. 8, pp. 1597-1608
Open Access | Times Cited: 224
Effective treatment of house dust mite–induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial
P. Démoly, W. Emminger, Dorte Rehm, et al.
Journal of Allergy and Clinical Immunology (2015) Vol. 137, Iss. 2, pp. 444-451.e8
Open Access | Times Cited: 214
Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma
Heimo Breiteneder, Yaqi Peng, Ioana Agache, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3039-3068
Open Access | Times Cited: 194
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation
Jean Bousquet, Holger J. Schünemann, João Fonseca, et al.
Allergy (2015) Vol. 70, Iss. 11, pp. 1372-1392
Open Access | Times Cited: 191
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
Stephen R. Durham, Martín Penagos
Journal of Allergy and Clinical Immunology (2016) Vol. 137, Iss. 2, pp. 339-349.e10
Closed Access | Times Cited: 190
2019 ARIA Care pathways for allergen immunotherapy
Jean Bousquet, Oliver Pfaar, Alkis Togias, et al.
Allergy (2019) Vol. 74, Iss. 11, pp. 2087-2102
Open Access | Times Cited: 165
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era
Joaquim Mullol, Antoine Azar, Kathleen M. Buchheit, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1434-1453.e9
Open Access | Times Cited: 86
Guideline on allergen immunotherapy in IgE-mediated allergic diseases
Oliver Pfaar, Tobias Ankermann, Matthias Augustin, et al.
Allergologie select (2022) Vol. 6, Iss. 01, pp. 167-232
Open Access | Times Cited: 79
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen‐induced rhinoconjunctivitis – an EAACI position paper
Oliver Pfaar, Katharina Bastl, Uwe Berger, et al.
Allergy (2016) Vol. 72, Iss. 5, pp. 713-722
Open Access | Times Cited: 149
The role of mobile health technologies in allergy care: An EAACI position paper
Paolo Maria Matricardi, Stephanie Dramburg, Alberto Álvarez‐Perea, et al.
Allergy (2019) Vol. 75, Iss. 2, pp. 259-272
Open Access | Times Cited: 129
Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy
Petra Zieglmayer, Margarete Focke‐Tejkl, René Schmutz, et al.
EBioMedicine (2016) Vol. 11, pp. 43-57
Open Access | Times Cited: 126
Perspectives in allergen immunotherapy: 2019 and beyond
Oliver Pfaar, Ioana Agache, F. de Blay, et al.
Allergy (2019) Vol. 74, Iss. S108, pp. 3-25
Open Access | Times Cited: 126
House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies
Moisés A. Calderón, Jörg Kleine‐Tebbe, Allan Linneberg, et al.
The Journal of Allergy and Clinical Immunology In Practice (2015) Vol. 3, Iss. 6, pp. 843-855
Open Access | Times Cited: 112
Prolonged efficacy of the 300IR 5‐grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
A. Didier, Hans‐Jørgen Malling, Margitta Worm, et al.
Clinical and Translational Allergy (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 105
Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32
Verena Niederberger, Angela Neubauer, Philippe Gevaert, et al.
Journal of Allergy and Clinical Immunology (2018) Vol. 142, Iss. 2, pp. 497-509.e9
Open Access | Times Cited: 99
ARIA guideline 2019: treatment of allergic rhinitis in the German health system
Ludger Klimek, Claus Bachert, Oliver Pfaar, et al.
Allergologie select (2019) Vol. 3, Iss. 01, pp. 22-50
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top